Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • EXPE vs GSK✓SelectedUSD · GSKEXPE vs GSK performance historyLatest closeAs of-1.77%11/20
Stock and ETF performance explorer

EXPE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+95.3%
GSK return
+97.4%
Excess return
-2.1%
Maximum drawdown
-70.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.8%-0.1%-1.6%-1.7%
7D-8.7%-5.3%-3.4%-6.6%
30D-17.6%-3.7%-13.9%-16.1%
3M-27.3%-7.3%-20.0%-24.8%
6M+8.6%-4.2%+12.8%+10.5%
YTD-16.4%+0.9%-17.3%-18.3%
1Y+0.9%+7.3%-6.4%-4.0%
3Y+76.9%+52.7%+24.2%+33.7%
5Y+36.3%+40.1%-3.8%+5.6%
All+95.3%+97.4%-2.1%+27.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling